Abstract
GEN EdgeVol. 5, No. 1 CRISPRElementary Claim: Sherlock Gains Patent Rights for Cas12 in DiagnosticsThe CRISPR diagnostics developer co-founded by Feng Zhang marries amplification and detection through patent licensed from China-based partnerAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:22 Feb 2023https://doi.org/10.1089/genedge.5.1.37AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 5Issue 1Jan 2023 Information© 2023 by GEN PublishingTo cite this article:Alex Philippidis.Elementary Claim: Sherlock Gains Patent Rights for Cas12 in Diagnostics.GEN Edge.Jan 2023.180-185.http://doi.org/10.1089/genedge.5.1.37Published in Volume: 5 Issue 1: February 22, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
